799 Mrv0541 02231215012D 25 27 0 0 0 0 999 V2000 2.3645 2.2713 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 9.5574 -1.0652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.8381 -2.2999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.6995 -1.0541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.6213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 1.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 1.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9520 -0.0931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7770 -0.0931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 1.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 1.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8165 0.5927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8165 2.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5640 1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5640 1.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2769 0.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9897 0.1861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7026 -0.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4187 0.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1284 -1.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1316 -0.2346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4124 -1.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8413 -1.4749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2702 -1.4804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.9863 -1.0707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 10 1 0 0 0 0 1 11 1 0 0 0 0 2 23 1 0 0 0 0 2 24 1 0 0 0 0 3 23 2 0 0 0 0 4 18 2 0 0 0 0 4 22 1 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 5 8 1 0 0 0 0 5 9 1 0 0 0 0 6 10 1 0 0 0 0 7 11 2 0 0 0 0 7 12 1 0 0 0 0 11 13 1 0 0 0 0 12 14 2 0 0 0 0 13 15 2 0 0 0 0 14 15 1 0 0 0 0 14 16 1 0 0 0 0 16 17 3 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 19 21 2 0 0 0 0 20 21 1 0 0 0 0 20 22 2 0 0 0 0 20 23 1 0 0 0 0 24 25 1 0 0 0 0 M END > DB00799 > drugbank > CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1 > InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3 > OGQICQVSFDPSEI-UHFFFAOYSA-N > C21H21NO2S > 351.462 > 351.129299611 > 2 > 46 > 1.681670895573363e-06 > 40.31083826871929 > 1 > 0 > 0 > 1 > ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate > 5.15 > 5.218740551666667 > -5.67 > 0 > 0 > 3 > 0 > 1.2257417412293548 > 39.19 > 97.88199999999998 > 5 > 0 > 7.50e-04 g/l > tetrahydrofolic acid > 1 > DB00799 > APRD01246 > approved; investigational > Tazarotene > Tazarotene; Tazarotène; Tazaroteno; Tazarotenum > 011312 Niacinamide 4% / Tazarotene 0.05%; Arazlo; Avage; Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05%; Duobrii; Fabior; Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.05%; Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.1%; Niacinamide 4% / Tazarotene 0.05%; Niacinamide 4% / Tazarotene 0.1%; Tazarotene; Tazarotene Cream; Tazorac > Zorac $$$$